menu
    • menu

    Company profile for ContraFect Corporation

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ContraFect is a clinical-stage biotechnology company focused on discovering and developing biologic therapies for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings. An estimated 700,000 deaths worldwide each year are attributed to antimicrobial-resistant infections. We intend to address life threatening infections using our therapeutic product candidates from our platform of ...
    ContraFect is a clinical-stage biotechnology company focused on discovering and developing biologic therapies for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings. An estimated 700,000 deaths worldwide each year are attributed to antimicrobial-resistant infections. We intend to address life threatening infections using our therapeutic product candidates from our platform of direct lytic agents (DLAs), which include lysins and amurin peptides.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ContraFect CorporationUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    28 Wells Ave Yonkers, NY 10701 (914) 207-2300
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.contrafect.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/contrafect-corp/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ContraFectCorp

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With PI
    ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With PI

    16 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/16/2760540/0/en/ContraFect-Announces-FDA-Clearance-of-CF-370-IND-Application-to-Proceed-With-Phase-1-Clinical-Study.html

    GLOBENEWSWIRE
    16 Oct 2023
    Share Share
    ContraFect to Present at the ASM/ESCMID Joint Conference on Drug Development
    ContraFect to Present at the ASM/ESCMID Joint Conference on Drug Development

    19 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/19/2745601/0/en/ContraFect-to-Present-at-the-ASM-ESCMID-Joint-Conference-on-Drug-Development.html

    GLOBENEWSWIRE
    19 Sep 2023
    Share Share
    ContraFect Announces Submission of IND Application to the FDA for CF-370
    ContraFect Announces Submission of IND Application to the FDA for CF-370

    18 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/18/2744662/0/en/ContraFect-Announces-Submission-of-IND-Application-to-the-FDA-for-its-Development-Candidate-CF-370.html

    GLOBENEWSWIRE
    18 Sep 2023
    Share Share
    ContraFect to Present at the World Anti-Microbial Resistance Congress 2023
    ContraFect to Present at the World Anti-Microbial Resistance Congress 2023

    28 Aug 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/08/28/2732525/0/en/ContraFect-to-Present-at-the-World-Anti-Microbial-Resistance-Congress-2023.html

    GLOBENEWSWIRE
    28 Aug 2023
    Share Share
    ContraFect Enters Into a Warrant Exercise Transaction for Proceeds of $9.6 M
    ContraFect Enters Into a Warrant Exercise Transaction for Proceeds of $9.6 M

    27 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/27/2695308/0/en/ContraFect-Enters-Into-a-Warrant-Exercise-Transaction-for-Proceeds-of-9-6-Million.html

    GLOBENEWSWIRE
    27 Jun 2023
    Share Share
    ContraFect Data Presentations at ASM Microbe 2023 the Power of the Company
    ContraFect Data Presentations at ASM Microbe 2023 the Power of the Company

    20 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/20/2691115/0/en/ContraFect-Data-Presentations-at-ASM-Microbe-2023-Demonstrate-the-Power-of-the-Company-s-Proprietary-Platform-to-Discover-New-Agents-Targeting-Antibiotic-Resistant-Gram-negative-Pa.html

    GLOBENEWSWIRE
    20 Jun 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search